References
- Bauer W, Chamberlin W, Horenstein S. Spinal demyelination in progressive multifocal leukoencephalopathy. Neurology 1969; 18: 287–288
- Berger J R, Koralnik I J. Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequences. N Engl J Med 2005; 353: 414–416
- Kleinschidt-Demasters B K, Tyler K L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta 1-a for multiple sclerosis. N Engl J Med 2005; 353: 369–374
- Koralnik I J. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?. Ann Neurol 2006; 60: 162–173
- Langer-Gould A, Atlas S W, Gree A J, Bollen A W, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375–381
- Shintaku M, Matsumoto R, Sawa H, Nagashima K. Infection with JC virus and possible dysplastic ganglion-like transformation of the cerebral cortical neurons in a case of progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2000; 59: 921–929
- Von Einsiedel R W, Fife T D, Aksamit A J, Cornford M E, Secor D L, Tomiyasu U, Itabashi H H, Vinters H V. Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J Neurol 1993; 240: 391–406
- Weber T, Trebst C, Frye S, et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997; 176: 250–254